FARAH NASRATY
Prescription History 1104244813
Internal Medicine - Hematology & Oncology in La Jolla, CA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for FARAH NASRATY, an active Hematology & Oncology specialist practicing in La Jolla, CA. Our medical registry currently tracks 17 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,227 documented patient claims. Among these therapy options, the most frequently utilized medication is Anastrozole, which accounts for 607 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other CA PrescribersVs. CA Avg |
|---|---|---|---|
| Anastrozole | 607 | $18.45▼ below CA avg | ▲ More than typical |
About Anastrozole: Anastrozole is used to treat breast cancer in women after menopause. Show more ▾ Some breast cancers are made to grow faster by a natural hormone called estrogen. Anastrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. In 2024, this provider wrote 607 Medicare prescriptions for Anastrozole, about 8.9 times the volume of the typical California prescriber of this medication (68). Medicare paid an average of $18.45 per fill, versus $20.79 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 1,468.6 30-Day Fills standardized to 30-day supplies 43,973 Days of Medication total across all patients in 2024 | |||
| Letrozole | 152 | $16.36▼ below CA avg | ▲ More than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 152 Medicare prescriptions for Letrozole, about 3.1 times the volume of the typical California prescriber of this medication (49.4). Medicare paid an average of $16.36 per fill, versus $22.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 337.8 30-Day Fills standardized to 30-day supplies 10,036 Days of Medication total across all patients in 2024 | |||
| Exemestane | 85 | $194.09 | ▲ More than typical |
About Exemestane: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Exemestane is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Exemestane decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. Exemestane is usually not used in women of childbearing age. A hormonal antineoplastic agent. In 2024, this provider wrote 85 Medicare prescriptions for Exemestane, about 3.1 times the volume of the typical California prescriber of this medication (27.5). Medicare paid an average of $194.09 per fill, versus $151.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 195 30-Day Fills standardized to 30-day supplies 5,850 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 79 | $24.94 | ▲ More than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 79 Medicare prescriptions for Tamoxifen Citrate, about 2.2 times the volume of the typical California prescriber of this medication (35.4). Medicare paid an average of $24.94 per fill, versus $24.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 183 30-Day Fills standardized to 30-day supplies 5,467 Days of Medication total across all patients in 2024 | |||
| Prochlorperazine Maleate | 43 | $10.58▼ below CA avg | ▲ More than typical |
About Prochlorperazine Maleate: This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Show more ▾ Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612) In 2024, this provider wrote 43 Medicare prescriptions for Prochlorperazine Maleate, about 1.5 times the volume of the typical California prescriber of this medication (29.2). Medicare paid an average of $10.58 per fill, versus $13.81 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 43 30-Day Fills standardized to 30-day supplies 616 Days of Medication total across all patients in 2024 | |||
| Dexamethasone | 36 | $15.50 | ≈ Typical |
About Dexamethasone: Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions, skin diseases, eye problems, breathing problems, bowel disorders, cancer, and immune system disorders. Show more ▾ It is also used as a test for an adrenal gland disorder (Cushing's syndrome). Dexamethasone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. An anti-inflammatory 9-fluoro-glucocorticoid. In 2024, this provider wrote 36 Medicare prescriptions for Dexamethasone, about the same volume as the typical California prescriber of this medication (35.2). Medicare paid an average of $15.50 per fill, versus $13.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 351 Days of Medication total across all patients in 2024 | |||
| LynparzaOlaparib | 36 | $11,982.84▼ below CA avg | ▲ More than typical |
About Lynparza: This medication is used to treat certain cancers (such as breast, ovarian, fallopian tube, pancreatic, peritoneal cancer, prostate). Show more ▾ Olaparib works by slowing or stopping the growth of cancer cells. An antineoplastic agent, Poly(ADP-ribose) Polymerase inhibitor. In 2024, this provider wrote 36 Medicare prescriptions for Lynparza, about 1.8 times the volume of the typical California prescriber of this medication (19.7). Medicare paid an average of $11,982.84 per fill, versus $13,765.53 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| Ondansetron Hcl | 32 | $7.45▼ below CA avg | ≈ Typical |
About Ondansetron Hcl: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 32 Medicare prescriptions for Ondansetron Hcl, about 1.2 times the volume of the typical California prescriber of this medication (27.8). Medicare paid an average of $7.45 per fill, versus $14.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 32 30-Day Fills standardized to 30-day supplies 625 Days of Medication total across all patients in 2024 | |||
| Gabapentin | 28 | $8.78▼ below CA avg | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2024, this provider wrote 28 Medicare prescriptions for Gabapentin, about a third of the volume of the typical California prescriber of this medication (80.2). Medicare paid an average of $8.78 per fill, versus $15.63 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 47.5 30-Day Fills standardized to 30-day supplies 1,425 Days of Medication total across all patients in 2024 | |||
| IbrancePalbociclib | 23 | $15,514.12 | ≈ Typical |
About Ibrance: Palbociclib is used to treat a certain type of breast cancer. Show more ▾ It works by slowing or stopping the growth of cancer cells. Has antineoplastic activity; specific inhibitor of cyclin-dependent kinases 4 & 6. In 2024, this provider wrote 23 Medicare prescriptions for Ibrance, about 83% of the volume of the typical California prescriber of this medication (27.6). Medicare paid an average of $15,514.12 per fill, versus $15,322.98 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2024 | |||
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $10.28▼ below CA avg | ▼ Less than typical |
About Venlafaxine Hcl Er: This medication is used to treat certain mental/mood disorders (such as depression, anxiety, panic attacks, and social anxiety disorder). Show more ▾ Venlafaxine belongs to a class of drugs known as serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain. A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT. In 2024, this provider wrote 20 Medicare prescriptions for Venlafaxine Hcl Er, about 71% of the volume of the typical California prescriber of this medication (28). Medicare paid an average of $10.28 per fill, versus $23.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2024 | |||
| EliquisApixaban | 19 | $876.55▼ below CA avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 19 Medicare prescriptions for Eliquis, about a quarter of the volume of the typical California prescriber of this medication (72.9). Medicare paid an average of $876.55 per fill, versus $923.33 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 28.5 30-Day Fills standardized to 30-day supplies 855 Days of Medication total across all patients in 2024 | |||
| VerzenioAbemaciclib | 16 | $14,240.06▼ below CA avg | ▼ Less than typical |
About Verzenio: This medication is used to treat certain types of breast cancer. Show more ▾ Abemaciclib works by slowing or stopping the growth of cancer cells. It belongs to a class of drugs known as kinase inhibitors. A cell cycle inhibitor. In 2024, this provider wrote 16 Medicare prescriptions for Verzenio, about 70% of the volume of the typical California prescriber of this medication (23). Medicare paid an average of $14,240.06 per fill, versus $14,627.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 16 30-Day Fills standardized to 30-day supplies 448 Days of Medication total across all patients in 2024 | |||
| Nystatin | 16 | $7.49▼ below CA avg | ▼ Less than typical |
About Nystatin: Nystatin is used to treat fungal skin infections. Show more ▾ Nystatin is an antifungal that works by stopping the growth of fungus. Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3. In 2024, this provider wrote 16 Medicare prescriptions for Nystatin, about 72% of the volume of the typical California prescriber of this medication (22.3). Medicare paid an average of $7.49 per fill, versus $20.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 16 30-Day Fills standardized to 30-day supplies 303 Days of Medication total across all patients in 2024 | |||
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $10.73▼ below CA avg | ▼ Less than typical |
About Lidocaine-Prilocaine: This medication contains 2 amide-type local anesthetics, lidocaine and prilocaine. Show more ▾ It is used on normal, unbroken skin or on the outer genital area to prevent pain before certain procedures such as inserting a needle, skin grafts, or skin laser surgery. It works by temporarily numbing the skin and surrounding area. Do not use this product in the ears. If this product alone cannot completely numb the area being treated, it may be used to numb the area before a lidocaine injection is given to provide enough pain relief for certain procedures (such as removal of genital warts). A topical local anesthetic preparation that is composed of a mixture of lidocaine and prilocaine. It is used to provide anesthesia during minor surgery and for the treatment of PREMATURE EJACULATION. In 2024, this provider wrote 12 Medicare prescriptions for Lidocaine-Prilocaine, about half the volume of the typical California prescriber of this medication (24.8). Medicare paid an average of $10.73 per fill, versus $20.14 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 12 30-Day Fills standardized to 30-day supplies 330 Days of Medication total across all patients in 2024 | |||
| LoperamideLoperamide Hcl | 12 | $13.63▼ below CA avg | ▼ Less than typical |
About Loperamide: See also Warning section. Show more ▾ This medication is used to treat sudden diarrhea (including traveler's diarrhea). It works by slowing down the movement of the gut. This decreases the number of bowel movements and makes the stool less watery. Loperamide is also used to reduce the amount of discharge in patients who have undergone an ileostomy. It is also used to treat on-going diarrhea in people with inflammatory bowel disease. Loperamide treats only the symptoms, not the cause of the diarrhea (such as infection). Treatment of other symptoms and the cause of the diarrhea should be determined by your doctor. One of the long-acting synthetic ANTIDIARRHEALS; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally. In 2024, this provider wrote 12 Medicare prescriptions for Loperamide, about half the volume of the typical California prescriber of this medication (23.1). Medicare paid an average of $13.63 per fill, versus $15.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CA average for this medication. 12 30-Day Fills standardized to 30-day supplies 127 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 11 | $14.08 | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 11 Medicare prescriptions for Alendronate Sodium, about 18% of the volume of the typical California prescriber of this medication (61). Medicare paid an average of $14.08 per fill, versus $9.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.1 30-Day Fills standardized to 30-day supplies 784 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for FARAH NASRATY is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this La Jolla, CA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among CA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
